CLPBY OTC
Coloplast A/S
1W: -4.3%
1M: -16.5%
3M: +1.3%
YTD: -26.2%
1Y: -28.4%
3Y: -36.9%
5Y: -59.0%
$6.18
-0.08 (-1.28%)
Weekly Expected Move ±2.6%
$6
$6
$6
$6
$7
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$48.5B
+0.8% ▲
5Y CAGR: +29.1%
Total Liabilities
$32.3B
+7.2% ▲
5Y CAGR: +39.6%
Shareholders Equity
$16.2B
-10.0% ▼
5Y CAGR: +16.9%
Cash & Investments
$949M
+20.4% ▲
5Y CAGR: +10.2%
Total Debt
$22.7B
+0.2% ▲
5Y CAGR: +67.0%
Net Debt
$21.7B
-0.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $448M | $414M | $911M | $788M | $949M |
| Short-Term Investments | $226M | $219M | $0 | $0 | $0 |
| Cash & ST Investments | $674M | $633M | $911M | $788M | $949M |
| Net Receivables | $3.4B | $4.3B | $4.6B | $5.0B | $5.2B |
| Inventory | $2.4B | $3.2B | $3.5B | $3.7B | $3.9B |
| Other Current Assets | $508M | $719M | $805M | $509M | $303K |
| Total Current Assets | $7.0B | $8.8B | $9.9B | $10.4B | $10.5B |
| Property, Plant & Equip. | $4.4B | $5.2B | $6.0B | $6.6B | $7.1B |
| Goodwill & Intangibles | $3.7B | $20.3B | $31.3B | $30.3B | $29.9B |
| Long-Term Investments | -$185M | -$168M | $104M | $74M | $115M |
| Other Non-Current Assets | $252M | $250M | $0 | $28M | $317M |
| Total Non-Current Assets | $8.8B | $26.2B | $38.2B | $37.6B | $38.0B |
| Total Assets | $15.8B | $35.0B | $48.2B | $48.1B | $48.5B |
| — Liabilities — | |||||
| Accounts Payable | $1.0B | $1.2B | $1.3B | $1.5B | $1.3B |
| Short-Term Debt | $2.2B | $1.6B | $7.1B | $5.1B | $2.6B |
| Deferred Revenue | $2.9B | $0 | $7.7B | $0 | $0 |
| Other Current Liabilities | $2.0B | $4.2B | $3.4B | $56M | $2.4B |
| Total Current Liabilities | $6.3B | $7.3B | $16.3B | $10.2B | $6.5B |
| Long-Term Debt | $0 | $16.4B | $11.6B | $16.6B | $19.4B |
| Other Non-Current Liab. | $237M | $396M | $6M | $155M | $2.7B |
| Total Non-Current Liabilities | $1.4B | $19.3B | $14.5B | $19.9B | $25.8B |
| Total Liabilities | $7.7B | $26.7B | $30.9B | $30.1B | $32.3B |
| — Equity — | |||||
| Common Stock | $216M | $216M | $228M | $228M | $228M |
| Retained Earnings | $5.4B | $5.4B | $14.6B | $15.4B | $17.7B |
| Accumulated OCI | -$433M | -$495M | -$1.2B | $0 | -$1.8B |
| Total Stockholders Equity | $8.2B | $8.3B | $17.3B | $17.9B | $16.2B |
| Total Liabilities & Equity | $15.8B | $35.0B | $48.2B | $48.1B | $48.5B |
| — Key Metrics — | |||||
| Total Debt | $2.8B | $18.7B | $19.6B | $22.6B | $22.7B |
| Net Debt | $2.3B | $18.3B | $18.7B | $21.8B | $21.7B |
| Total Investments | $41M | $51M | $65M | $74M | $115M |